Swedish primary care registry data show underuse and wide between-centre variation in SGLT2 inhibitor and GLP-1 receptor agonist dispensing among patients with ischaemic heart disease and type 2 diabetes, with higher estimated prescription costs under ESC-guideline use

Swedish primary care registry data show underuse and wide between-centre variation in SGLT2 inhibitor and GLP-1 receptor agonist dispensing among patients with ischaemic heart disease and type 2 diabetes, with higher estimated prescription costs under ESC-guideline use - Vera Health News